Redhill Biopharma Ltd-sp Adr (RDHL) Institutional Ownership & 13F Filings (Q2 2026)

RDHL ranks #9082 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

RDHL is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

15 institutions disclose a position in RDHL, but none treat it as a major bet — even Yorkville Advisors Global, LP, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Rhumbline Advisers has added to its RDHL position for two straight quarters, increasing it by $8.9K to reach $11.6K today.

Yorkville Advisors Global, LP has trimmed its RDHL position for two straight quarters, cutting it by $291.5K while still holding $106.7K.

RDHL reported a net loss of $67.8M over the trailing twelve months.

• Not yet profitable — net loss of $67.8M over the trailing twelve months
• Revenue grew 34.5% year over year
• Net income declined year over year, from -$67.2M to -$67.8M
• Operating cash flow was negative, using $9.7M in cash
• Current ratio of 0.34x — below the conventional 1.5x liquidity buffer